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Abstract: Childhood asthma is a recurring health burden and symptoms of severe asthma 
in children are also emerging as a health and economic issue. This  study examined 
changing patterns in symptoms of severe asthma and allergies (ever eczema and hay fever), 
using the Irish International Study of Asthma and Allergies in Childhood (ISAAC) 
protocol. ISAAC is a cross-sectional self-administered questionnaire survey of randomly 
selected representative post-primary schools.  Children aged 13–14 years were studied: 
2,670 (in 1995), 2,273 (in 1998), 2,892 (in 2002–2003), and 2,805 (in 2007). Generalized 
linear modelling using Poisson distribution was employed to compute adjusted prevalence 
ratios (PR). A 39% significant increase in symptoms of severe asthma was estimated in 
2007 relative to the baseline year 1995 (adjusted PR: 1.39 [95% CI: 1.14–1.69]) increasing 
from 12% in 1995 to 15.3% in 2007. Opposite trends were observed for allergies, showing 
a decline in 2007, with an initial rise.  The  potential explanations for such a complex 
disease pattern whose aetiological hypothesis is still evolving are speculative. Changing 
environmental factors may be a factor, for instance, an improvement in both outdoor and 
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indoor  air  quality  further reinforcing  the hygiene hypothesis  but  obesity as a disease 
modifier must also be considered. 
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1. Introduction 
Asthma is one of the most common non-communicable diseases in children, and its prevalence 
varies worldwide [1]. The increase in asthma prevalence in developed countries seen at the end of last 
century has raised concern for the considerable burden of this disease on society as well as individuals. 
The International Study of Asthma and Allergies in  Childhood (ISAAC), using a simple and 
inexpensive standardized methodology, has provided valuable data on the prevalence of the symptoms 
of childhood asthma and allergies for international comparison from countries with  different  
socio-economic backgrounds.  
Ireland has the fourth highest prevalence of asthma in the World [2].
 Approximately 470,000 people 
have asthma in Ireland and 6,300 people have severe asthma  [3]. The European Community 
Respiratory Health Survey (ECRHS) reported that Ireland has the highest prevalence of severe asthma 
attacks (6%) over the past 12 months among patients aged 20–44 years across Europe [4]. Asthma can 
be a persisting and recurring health problem, thus increasing the likelihood of health, social, and 
economic costs for these individuals, their families and also on the healthcare system. Ireland has the 
highest rate of asthma-related hospitalizations in Europe [4]. A recent ISAAC Phase Three study also 
suggested that the prevalence rates of symptoms of severe asthma can be used as surrogates of both 
disease burden and health care utilization patterns [5].  
Furthermore, the prevalence of symptoms of severe asthma has been shown to correlate more 
strongly than that of current wheeze alone with national asthma hospitalization and mortality rates 
particularly in 13–14 year age-groups [6]. While the clinical significance of having only one wheezing 
episode in a year is questionable, the occurrence of frequent, sleep-disturbing or speech-limiting 
attacks is widely accepted as clinically important. The latter two symptoms, in particular, are highly 
specific for bronchial hyperresponsiveness to methacholine [7]. Severe or frequent symptoms are also 
less likely to go unnoticed by subjects who have no family history of asthma and come from deprived 
family backgrounds  [8].  The ENFUMOSA (European Network for Understanding  Mechanisms of 
Severe Asthma)  study was the first comprehensive assessment of severe asthma across Europe to 
conclude that features of severe asthma are distinct from those described for mild-to-moderate disease [9]. 
Ireland has reported earlier of an increasing trend in ‘ever’ asthma and wheeze symptoms but it is 
unclear whether symptoms of severe asthma have changed significantly between the four Irish ISAAC 
waves (1995, 1998, 2002/2003, 2007). As an objective assessment we looked at changing patterns in 
the  usage of any inhaler (not necessarily corticosteroids) across the four surveys. In addition, the 
changing patterns in prevalence rates of allergic symptoms (hay fever and eczema) in school-children 
aged 13–14 years across the four Irish ISAAC waves were determined. 
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2. Methods 
2.1. Study Population 
The study population included school children in Ireland aged 13–14 years. Two previous identical 
waves were undertaken, the first in 1995 and the second in 1998 (both in Spring). Another two similar 
waves were undertaken, the third between October 2002 and May 2003, and the fourth was conducted 
in Spring 2007. The International Study on Asthma and Allergies in Children (ISAAC) study is 
specifically designed to examine for prevalence of asthma, rhinitis and eczema in children aged   
13–14 years. Details on the Irish ISAAC study have been reported elsewhere [10,11].  
2.2. Sampling Design 
In the previous 3 surveys, the basic sampling frame consisted of 624 post primary schools, while for 
the 2007 survey 731 post-primary schools were used as the sampling frame. More importantly, the first 
two surveys had identical schools while the latter two surveys had two-third schools of the initial two 
surveys. A few new schools were included in the last two surveys as those schools initially recruited in 
the first two surveys were either closed or were not eager to participate in the succeeding surveys. 
Also, the pupil strength and the number of schools in recent years have grown, thereby, increasing the 
sampling frame for the last survey in particular.  
In all the surveys special disability schools and schools with less than 40 pupils of this age group 
were excluded because of the impracticalities of administrating the surveys. A multi-stage stratified 
random sampling technique was employed to require at least 3,000 pupils in consistent with the 
ISAAC protocol. A random sample of schools was selected from the sampling frame, proportionally 
stratified by size of school, sex of pupils in school (male, female or mixed) and by administrative 
Health Areas. The stratification procedure ensured that the schools were fully representative of the 
population across the specified variables. From each school, classes with the greatest proportion of  
13–14 year olds were selected with at least 40 pupils in each class.  
The identical survey questionnaire, methods, age groups and schools (n = 30) of the 1995 survey 
were included in the second survey in the Spring of 1998. However, for the 2002/2003 survey, of the 
potential 36 schools to target a population of 3,080 pupils 4 schools chose not to participate, and 
therefore 10 new schools were included compared to 1995 and 1998 surveys. For the fourth survey in 
2007, 39 schools were initially contacted but 35 schools finally participated in the 2007 survey.  
2.3. Study Instrument 
The questionnaires used in all the four waves were self administered under supervision by the 
researchers on each occasion. In this study, we estimated the prevalence of asthma symptoms based on 
the responses to the written questionnaire on (a) wheeze in the past 12 months (current wheeze) and  
(b) frequent or severe episodes of wheeze in the past 12 months (symptoms of severe asthma). 
Symptoms of severe asthma are defined as those with current wheeze who, according to the written 
questionnaire, in the past 12 months, have had >4 attacks of wheeze, or >1 night per week sleep 
disturbance from wheeze, or wheeze affecting speech. This definition is based on previous ISAAC 
analyses that showed a combination of these features of more severe wheezing episodes correlated Int. J. Environ. Res. Public Health 2011, 8                 
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more closely with asthma mortality and hospital admissions than current wheeze alone [5,6]. Allergies 
(‘ever’ eczema and ‘ever’ hay fever symptoms) were defined from the questions “have you ever had 
eczema/hay fever?” 
2.4. Statistical Analyses 
Only those aged 13–14 years were included in the final analyses, and therefore the total number of 
respondents for each of the survey years is not identical to previous published Irish ISAAC studies [11]. 
A generalized linear model was employed using Proc Genmod of SAS software (version 9.1.1, Cary, 
NC, USA) for computing adjusted prevalence ratios (PR) for each of the survey years, using the first 
calendar year 1995 as the reference category. A Poisson distribution with a log link was found 
appropriate for estimating count data and the goodness-of-fit for models showed no over-dispersion. 
Prevalence ratios were computed instead of odds ratios as the main outcome of interest, namely, the 
symptoms of severe asthma was not a common occurrence in the study population  (~15% in 
prevalence). The log regression coefficients thus computed were exponentiated to get the prevalence 
ratios. 95% confidence intervals (CI) were computed based on the standard error estimates.  
In addition, interactions with calendar year were performed for potential covariates such as sex, 
smoking status of the study participants (current and secondhand smoke exposure), and school 
distribution for the health outcomes analysed. Also, interaction terms for calendar year and allergies 
were performed for the main outcome studied, namely, the symptoms for severe asthma. However, the 
final models did not include any of the above interaction terms analysed as each of the terms was 
found not significant statistically. Also, no results by sex distribution were shown as no effect 
modification was observed for any of the health outcomes analysed across the survey years. 
Nevertheless, adjusted prevalence ratios accounted for all the potential covariates available to the 
study, namely, sex, medication usage, clustering effect of schools, pet exposure, smoking status   
(both current and secondhand smoke exposure), and current wheeze and allergies for the main 
outcome of interest. Interesting to note that no effect modification of school distribution by calendar 
years was observed on the health outcomes analysed, thus favouring the representativeness of the 
schools recruited. 
2.5. Ethics 
Ireland  (both  LC and PJM) was a partner of the international ISAAC survey committee. Irish 
ISAAC 1995 had ethical approval from Peamount Hospital Ethics Committee (Dublin), ISAAC 1998 
and 2002 got ethical approval from the Federated Hospitals (St. James’s and Tallaght Hospitals) Ethics 
Committee both in Dublin. The last ISAAC survey in 2007 got ethical approval from the Irish College 
of General Practitioners’ Ethics Committee. 
3. Results 
A total of 10, 647 participants were studied (Table 1). Table 1 also shows that symptoms of severe 
asthma increased significantly to 39% in 2007 (adjusted prevalence ratio: 1.39 [95% CI: 1.14–1.69]) 
relative to 1995 from 12% in 1995 to 15.3% in 2007.  Int. J. Environ. Res. Public Health 2011, 8                 
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Table 1. Adjusted Prevalence Ratios (PR) of symptoms of severe asthma and inhaler usage 
among Irish school children aged 13–14 years, 1995–2007 (n = 10,647). 
Year 
*Symptoms of Severe Asthma  Inhaler Usage 
Prevalence % 
Prevalence Ratios (PR)  Prevalence Ratios (PR) 
Unadjusted  
[95% CI] 
Adjusted**  
[95% CI] 
Adjusted**  
[95% CI] 
1995 (n = 2,671)  12.0  1.00 (reference)  1.00 (reference)  1.00 (reference) 
1998 (n = 2,273)  11.4  0.95 (0.80–1.11)  0.90 (0.76–1.07)  1.13 (0.96–1.33) 
2002 (n = 2,894)  8.7  0.72 (0.61–0.85)
 a  0.76 (0.62–0.92)
 a  1.00 (0.84–1.19) 
2007 (n = 2,809)  15.3  1.27 (1.10–1.47)
 a  1.39 (1.14–1.69)
 a  1.31 (1.11–1.56)
 a 
* Respondents with current wheeze who had 4 or more attacks of wheeze in the last year or had 1 or more 
nights per week sleep disturbance from wheeze in the last year or had wheeze affecting speech in the last year. 
** Adjusted simultaneously for sex; medications; pet exposure; current active smoking status alone; 
secondhand smoke exposure alone; allergies (hay and eczema symptoms ever) [not for inhaler usage]; 
clustering effect within schools; wheeze alone [not for inhaler usage]. 
a Statistically significant. 
As an objective assessment, any inhaler usage for the same periods have also increased significantly 
of a similar magnitude and direction, with an estimated increase of 31% in 2007 (adjusted PR: 1.31 
[95%CI: 1.11–1.56]). However, the observed significant decline in symptoms of severe asthma in 
2002 survey year corresponded well in magnitude and direction to any inhaler usage for the same 
calendar year but the decline was not significant statistically (adjusted PR: 1.00 [95% CI: 0.84–1.19] 
vs. 0.76 [95% CI: 0.62–0.92]) for inhaler usage and symptoms of severe asthma, respectively.  
Table 2 shows that symptoms of ever eczema peaked significantly to 40% in 2002 (adjusted 
prevalence ratio: 1.40 [95% CI: 1.16–1.69]) relative to 1995 from 9.4% in 1995 to 14.4% in 2002 but 
showed a marginal decline to 13.2% in 2007 (adjusted prevalence ratio: 1.31 [95% CI: 1.11–1.56]). 
Table 2. Unadjusted and adjusted Prevalence Ratios (PR) of symptoms of ever eczema 
among Irish school children aged 13–14 years, 1995–2007 (n = 10,647). 
Year 
Symptoms of Ever Eczema 
Prevalence  Prevalence Ratios (PR) 
%  Unadjusted  
[95% CI] 
Adjusted**  
[95% CI] 
1995 (n = 2,671)  9.4  1.00 (reference)  1.00 (reference) 
1998 (n = 2,273)  10.4  1.11 (0.93–1.33)  1.06 (0.89–1.27) 
2002 (n = 2,894)  14.4  1.54 (1.32–1.80)
 a  1.40 (1.16–1.69)
 a 
2007 (n = 2,809)  13.2  1.41 (1.20–1.65)
 a  1.31 (1.07–1.59)
 a 
**  Adjusted simultaneously for sex; medications; pet exposure; current active smoking status alone; 
secondhand smoke exposure alone; hay fever symptoms ever; clustering effect within schools; wheeze past 
12months; symptoms of severe asthma. 
a Statistically significant. 
Table 3 shows that symptoms of hay fever peaked significantly to 29% in 2002 (adjusted 
prevalence ratio: 1.29 [95% CI: 1.15–1.45]) relative to 1995 from 25% in 1995 to 31.3% in 2002 but Int. J. Environ. Res. Public Health 2011, 8                 
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showed a larger statistically non-significant decline almost similar in magnitude to the baseline year of 
1995 in 2007, namely, 25.2% (adjusted prevalence ratio: 1.05 [95% CI: 0.93–1.20]).  
Table 3. Unadjusted and adjusted Prevalence Ratios (PR) of symptoms of ever hay fever 
among Irish school children aged 13–14 years, 1995–2007 (n = 10,647). 
Year 
Symptoms of Ever Hay Fever 
Prevalence  Prevalence Ratios (PR) 
%  Unadjusted  
[95% CI] 
Adjusted**  
[95% CI] 
1995 (n = 2,671)  25.0  1.00 (reference)  1.00 (reference) 
1998 (n = 2,273)  28.7  1.15 (1.03–1.28)
 a  1.13 (1.01–1.26)
 a 
2002 (n = 2,894)  31.3  1.25 (1.13–1.38)
 a  1.29 (1.15–1.45)
 a 
2007 (n = 2,809)  25.2  1.01 (0.91–1.12)  1.05 (0.93–1.20) 
**  Adjusted simultaneously for sex; medications; pet exposure; current active smoking status alone; 
secondhand smoke exposure alone; eczema symptoms ever; clustering effect within schools; wheeze past 12 
months; symptoms of severe asthma. 
a Statistically significant. 
4. Discussion 
This study highlights that childhood asthma, especially symptoms of severe asthma, in Ireland is 
still a public health issue when we estimated a significant increase in prevalence of symptoms of 
severe asthma in 2007 relative to the baseline year 1995 (an estimated increase of 39%). Further, the 
estimates are similar to the estimates for any inhaler usage for the corresponding years in both 
magnitude and direction, thus reinforcing the observed increase in the symptoms of severe asthma 
through a rather crude objective indicator, namely, any inhaler usage. However, a decline was also 
observed in between the successive years and the estimated decline was significant statistically only 
for the calendar year 2002. In contrast, opposite trends were observed for allergies. A significant fall in 
allergies, especially symptoms of ever hay fever was determined in 2007 almost corresponding to the 
baseline year prevalence. On the contrary, symptoms of ever eczema continued to rise with a 
deceleration in the most recent year. Such observations are complex and need further explorations in 
well-defined longitudinal studies. Nonetheless, the observed increase in symptoms of severe asthma 
can be either attributed to changing environmental factors or to better recognition and diagnosis of 
asthma in clinical practice or both. 
While much of asthma has a genetic basis, the increasing rise in asthma rates is unlikely to be 
explained by genetic factors alone and may reflect other issues such as changing but unexplained 
environment factors [1,5], and also due to an increased awareness of the condition particularly in 
milder disease [12]. One of the striking environmental changes that occurred in Ireland during these 
study periods from 1995 onwards is the dramatic improvement in urban air quality [13]. Studies have 
shown consistently that the introduction of banning bituminous coal initially in Dublin and then 
gradually expanding all across Ireland had an improvement in health outcomes in the general Irish 
population [14,15].  The next significant legislation was the introduction of the comprehensive 
workplace smoke-free policy in Ireland in March 2004. Evidence in Ireland also suggests that the 
comprehensive workplace smoke-free legislation improved health outcomes both in children and in Int. J. Environ. Res. Public Health 2011, 8                 
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adults [10,16]. A recent study reported a significant decline in current smoking status of Irish children 
aged 13–14 years between 1995 and 2007 [10]. The same study also concluded that no significant 
changes  occurred  to childhood secondhand exposure levels inside homes, using the Irish ISAAC 
protocol [10]. Recent evidence in Scotland, however, convincingly demonstrated that comprehensive 
smoke-free legislation did contribute to an 18.2% yearly decline in childhood asthma hospitalization 
rates [17].  
Other environmental lifestyle factors possibly contributing to the observed increase in symptoms of 
severe asthma may be the increasing upward trend in childhood obesity [18]. A recent 13-year follow-up 
study showed a significant relationship between adult onset of asthma incidence and obesity [19]. On 
the physiological level, adipose tissue might be actively involved in inflammatory processes and there 
might be a causal link between obesity and chronic inflammatory airway disease [20]. A recent   
review [21] found a fairly consistent association between weight loss and improved asthma, which is 
an important epidemiological criterion of causality. A recent meta-analysis also showed a 50% 
increased risk of asthma in overweight/obese individuals, with a dose-response effect [22]. We also 
reported that obese adults in Ireland are one and half-times more likely to report physician-diagnosed 
asthma after adjusting for potential covariates, including smoking status [23]. Unfortunately, the Irish 
ISAAC survey has no information on obesity. 24% of Irish adults >18 years of age are reported to be 
obese in a recent nationwide survey [24]. 
There is epidemiological evidence suggesting  that sub-optimal asthma management is a global 
phenomenon [25], and European nations are also included [26]. The launch and the wide dissemination 
of the Irish evidence-based Asthma Management Guidelines  might have contributed to changes in 
perception [27]. The guidelines support the early use of inhaled anti-inflammatory corticosteroids, an 
effective anti-inflammatory asthma therapy in children. Furthermore, there may be less awareness of 
wheeze  being a symptom of asthma, even in those with frequent wheezing  [28].  Children with 
undiagnosed frequent symptoms are also more likely to receive inadequate care for their asthma and 
may fall into a vicious downward spiral of asthma control [28]. But not all of the paradoxical increase 
in asthma prevalence could be explained by such a phenomenon, especially the apparent reversal in 
trend in the symptoms of severe asthma in the most recent survey in 2007.  
5. Strengths and Limitations of the Study 
The main strength of the study is a large cross-sectional  survey design employing a uniform 
internationally validated ISAAC methodology. Identical schools for the first two surveys and 
recruiting two-thirds of the schools initially sampled for the latter two surveys also addresses the issue 
of selection bias coupled with a proportional random stratified sampling technique adopted for all the 
four waves.  During analyses, the generalized linear modelling accounted  for linearity using a   
non-linear log link for Poisson distribution and the adjustments for potential covariates influencing any 
underlying temporal patterns together could have addressed salient weaknesses encountered in the 
design phase. Nonetheless, cross-sectional study designs have inherent methodological limitations, for 
instance no causal association. Self-reported paediatric health outcomes may be either over or under 
reported.  Detailed information on socio-economic status or on  other unmeasured/unidentified 
confounders such as parental allergies was  not available to all the four Irish ISAAC surveys Int. J. Environ. Res. Public Health 2011, 8                 
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introducing residual confounding. However, adjustments for clustering effect within schools and the 
lack of  effect modification of  schools by calendar years on  the health outcomes studied further 
reinforce minimal or no selection bias in terms of socio-economic status.  
6. Conclusions 
In conclusion, this study indicates that symptoms of severe asthma are emerging as both a clinical 
and a public health problem in Ireland, thus increasing the likelihood of health, social, and economic 
costs for these children, their families and  also on  the  national healthcare system.  Although the 
observed patterns are complex and merit further explorations through well-designed longitudinal 
studies, speculations around some potential environmental changes, for instance, a cleaner air may 
provide additional clues to the hygiene hypothesis. The current improved status of an outdoor and 
indoor air quality did contribute to a cleaner environment for Irish children but that may be offset by 
the rising childhood obesity epidemic with long-term childhood health consequences. In short, the 
aetiological hypothesis of childhood asthma and more recently the symptoms of severe asthma are 
continually evolving that merits attention. 
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